These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 6480289

  • 1. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
    Sava G, Giraldi T, Zupi G, Sacchi A.
    Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289
    [Abstract] [Full Text] [Related]

  • 2. Effects of dimethyltriazenes on in vitro Lewis lung carcinoma tumor lines with different metastatic capacity.
    Zupi G, Corsi A, Sacchi A, Lassiani L, Giraldi T.
    Invasion Metastasis; 1984; 4(3):179-88. PubMed ID: 6480290
    [Abstract] [Full Text] [Related]

  • 3. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G, Giraldi T, Lassiani L, Nisi C.
    Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
    [Abstract] [Full Text] [Related]

  • 4. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T, Sava G, Cuman R, Nisi C, Lassiani L.
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [Abstract] [Full Text] [Related]

  • 5. Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice.
    Giraldi T, Houghton PJ, Taylor DM, Nisi C.
    Cancer Treat Rep; 1978 May; 62(5):721-5. PubMed ID: 657157
    [Abstract] [Full Text] [Related]

  • 6. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma.
    Sava G, Giraldi T, Nisi C, Bertoli G.
    Cancer Treat Rep; 1982 Jan; 66(1):115-20. PubMed ID: 7053247
    [Abstract] [Full Text] [Related]

  • 7. Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Sava G, Zorzet S, Perissin L, Lassiani L, Tomasic J.
    Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):477-80. PubMed ID: 4079598
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Infiltration of liver and brain by tumor cells in leukemic mice: prevention by dimethyltriazenes and cyclophosphamide.
    Sava G, Giraldi T, Perissin L, Zorzet S, Mallardi F, Grill V.
    Tumori; 1984 Dec 31; 70(6):477-83. PubMed ID: 6531789
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Varnavas A, Nisi C, Lassiani L, Sava G, Perissin L, Boccù E.
    Arzneimittelforschung; 1991 Nov 31; 41(11):1168-72. PubMed ID: 1810263
    [Abstract] [Full Text] [Related]

  • 11. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
    Giraldi T, Sava G, Mitri E, Cherubino R.
    Eur J Cancer Clin Oncol; 1984 Jul 31; 20(7):961-6. PubMed ID: 6540195
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
    Colombo T, D'Incalci M.
    Cancer Chemother Pharmacol; 1984 Jul 31; 13(2):139-41. PubMed ID: 6467499
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activity of 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt in M 5076/73A ovarian reticular cell sarcoma of the mouse.
    Colombo T, Garattini S, Lassiani L, D'Incalci M.
    Cancer Treat Rep; 1982 Nov 31; 66(11):1945-8. PubMed ID: 6754075
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma.
    Grill V, Mallardi F, Zorzet S, Perissin L, Giraldi T.
    Clin Exp Metastasis; 1987 Sep 31; 5(3):233-44. PubMed ID: 3652553
    [Abstract] [Full Text] [Related]

  • 18. Different metastatic potential of in vitro and in vivo lines selected from Lewis lung carcinoma: correlation with response to different bleomycin schedulings.
    Sacchi A, Calabresi F, Greco C, Zupi G.
    Invasion Metastasis; 1981 Sep 31; 1(4):227-38. PubMed ID: 6203864
    [Abstract] [Full Text] [Related]

  • 19. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
    Sava G, Zorzet S, Turrin C, Vita F, Soranzo M, Zabucchi G, Cocchietto M, Bergamo A, DiGiovine S, Pezzoni G, Sartor L, Garbisa S.
    Clin Cancer Res; 2003 May 31; 9(5):1898-905. PubMed ID: 12738748
    [Abstract] [Full Text] [Related]

  • 20. The influence of surgical procedure and the effect of chemotherapy on nodal and distant metastases of human malignant melanomas that have been grafted into nude mice.
    Oguni A, Umeda M, Shigeta T, Takahashi H, Komori T.
    Int J Oral Maxillofac Surg; 2010 Jan 31; 39(1):42-9. PubMed ID: 19962277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.